Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ojeda

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
HIV Medicine|March 4, 2014
Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life settingJ Macías, E Recio, M Márquez, et al.
Cancer|June 1, 1978
Non-Hodgkin's lymphoma in children: an analysis of 122 cases from ArgentinaA Cebrian-Bonesana, E Schvartzman, C Roca-Garcia, et al.
Sangre|January 1, 1974
[Treatment of acute lymphoblastic leukemia. Evaluation of 6-year-cooperative studies in Argentina (author's transl)]F Sackmann Muriel, M Eppinger-Helft, J L Braier, et al.
Journal of Analytical Toxicology|May 26, 2018
Saxitoxin Exposure Confirmed by Human Urine and Food AnalysisR M Coleman, G Ojeda-Torres, W Bragg, et al.
Surgical Endoscopy|November 2, 2007
Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter studyJ Devière, G Ojeda Valdes, L Cuevas Herrera, et al.
Biochemical Pharmacology|February 18, 2016
ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritisL Aragoneses-Fenoll, M Montes-Casado, G Ojeda, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 20, 2012
Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapyJ Macías, M M Viloria, A Rivero, et al.
Cancer|October 1, 1978
Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemiaF Sackmann-Muriel, E Svarch, M Eppinger-Helft, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 28, 2015
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopeniaJ A Mira, K Neukam, L F López-Cortés, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
HIV Medicine|March 4, 2014
Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life settingJ Macías, E Recio, M Márquez, et al.
Cancer|June 1, 1978
Non-Hodgkin's lymphoma in children: an analysis of 122 cases from ArgentinaA Cebrian-Bonesana, E Schvartzman, C Roca-Garcia, et al.
Sangre|January 1, 1974
[Treatment of acute lymphoblastic leukemia. Evaluation of 6-year-cooperative studies in Argentina (author's transl)]F Sackmann Muriel, M Eppinger-Helft, J L Braier, et al.
Journal of Analytical Toxicology|May 26, 2018
Saxitoxin Exposure Confirmed by Human Urine and Food AnalysisR M Coleman, G Ojeda-Torres, W Bragg, et al.
Surgical Endoscopy|November 2, 2007
Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter studyJ Devière, G Ojeda Valdes, L Cuevas Herrera, et al.
Biochemical Pharmacology|February 18, 2016
ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritisL Aragoneses-Fenoll, M Montes-Casado, G Ojeda, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 20, 2012
Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapyJ Macías, M M Viloria, A Rivero, et al.
Cancer|October 1, 1978
Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemiaF Sackmann-Muriel, E Svarch, M Eppinger-Helft, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 28, 2015
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopeniaJ A Mira, K Neukam, L F López-Cortés, et al.
Pageof 6